Fujifilm Diosynth Biotechnologies Opens New Manufacturing Facility - - BioPharm International

ADVERTISEMENT

Fujifilm Diosynth Biotechnologies Opens New Manufacturing Facility


Fujifilm Diosynth Biotechnologies formally opened its new mammalian cell culture cGMP manufacturing facility in the United Kingdom, the company reported in a press release. The new facility, which was built and commissioned in less than 15 months, is the first facility of its kind in the UK that was purpose-built to use primarily single-use technologies for both upstream and downstream operations. It has initially been commissioned with 200-L and 1000-L bioreactors, with a 2000-L bioreactor planned for 2014. The company is working on its first customer project for the facility.

This new capacity is the latest in a series of investments at both Fujifilm Diosynth Biotechnologies’ UK and Research Triangle Park, NC, US facilities over the past two years. New cell-line development and process-development laboratories have been set up at both sites, and a 1000-L single-use bioreactor was installed at the US facility two years ago to supplement its 2000-L stainless-steel train for the GMP production of mammalian cell-culture biopharmaceuticals.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines

Click here